410 related articles for article (PubMed ID: 29357190)
1. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans.
Llewellyn HP; Vaidya VS; Wang Z; Peng Q; Hyde C; Potter D; Wang J; Zong Q; Arat S; Martin M; Masek-Hammerman K; Warner R; Johnson K; Kullak-Ublick GA; Aithal GP; Dear JW; Ramaiah SK
Toxicol Sci; 2021 Apr; 181(1):23-34. PubMed ID: 33483742
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage.
Cueto-Sánchez A; Niu H; Álvarez-Álvarez I; López-Longarela B; Del Campo-Herrera E; Ortega-Alonso A; García-Cortés M; Pinazo-Bandera J; Sanabria-Cabrera J; Díaz-Mochón JJ; Lucena MI; Andrade RJ; Stephens C; Robles-Díaz M
Br J Clin Pharmacol; 2023 Aug; 89(8):2497-2507. PubMed ID: 36965054
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).
Scullion KM; MacIntyre IM; Sloan-Dennison S; Clark B; Fineran P; Mair J; Creasey D; Rathmell C; Faulds K; Graham D; Webb DJ; Dear JW
Toxicol Sci; 2024 May; 199(2):203-209. PubMed ID: 38521541
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection.
Rupprechter SAE; Sloan DJ; Oosthuyzen W; Bachmann TT; Hill AT; Dhaliwal K; Templeton K; Matovu J; Sekaggya-Wiltshire C; Dear JW
Br J Clin Pharmacol; 2021 Aug; 87(8):3206-3217. PubMed ID: 33432705
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
[TBL] [Abstract][Full Text] [Related]
7. Latest advances in diagnosing and predicting DILI: what was new in 2017?
Barnhill MS; Real M; Lewis JH
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1033-1043. PubMed ID: 30111182
[TBL] [Abstract][Full Text] [Related]
8. The transformation in biomarker detection and management of drug-induced liver injury.
Church RJ; Watkins PB
Liver Int; 2017 Nov; 37(11):1582-1590. PubMed ID: 28386997
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat.
Thulin P; Hornby RJ; Auli M; Nordahl G; Antoine DJ; Starkey Lewis P; Goldring CE; Park BK; Prats N; Glinghammar B; Schuppe-Koistinen I
Biomarkers; 2017 Jul; 22(5):461-469. PubMed ID: 27978773
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.
Mikus M; Drobin K; Gry M; Bachmann J; Lindberg J; Yimer G; Aklillu E; Makonnen E; Aderaye G; Roach J; Fier I; Kampf C; Göpfert J; Perazzo H; Poynard T; Stephens C; Andrade RJ; Lucena MI; Arber N; Uhlén M; Watkins PB; Schwenk JM; Nilsson P; Schuppe-Koistinen I
Liver Int; 2017 Jan; 37(1):132-140. PubMed ID: 27224670
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.
Umbaugh DS; Jaeschke H
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):363-375. PubMed ID: 33242385
[No Abstract] [Full Text] [Related]
12. Assessment of emerging biomarkers of liver injury in human subjects.
Schomaker S; Warner R; Bock J; Johnson K; Potter D; Van Winkle J; Aubrecht J
Toxicol Sci; 2013 Apr; 132(2):276-83. PubMed ID: 23339181
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
[TBL] [Abstract][Full Text] [Related]
14. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
Church RJ; Watkins PB
Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers of isoniazid-induced liver injury: Aminotransferases are insufficient, and OPN, L-FABP and HMGB1 can be promising novel biomarkers.
Cheng X; Zhu JL; Li Y; Luo WW; Xiang HR; Zhang QZ; Peng WX
J Appl Toxicol; 2022 Mar; 42(3):516-528. PubMed ID: 34494278
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of IL-6/IL-10/GLDH may be early recognition markers of anti-tuberculosis drugs (ATB) -induced liver injury.
Xiang HR; Li Y; Cheng X; He B; Li HM; Zhang QZ; Wang B; Peng WX
Toxicol Appl Pharmacol; 2023 Sep; 475():116635. PubMed ID: 37487937
[TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers of drug-induced liver injury: Current status and future directions.
Church RJ; Watkins PB
J Dig Dis; 2019 Jan; 20(1):2-10. PubMed ID: 30378260
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.
Antoine DJ; Dear JW; Lewis PS; Platt V; Coyle J; Masson M; Thanacoody RH; Gray AJ; Webb DJ; Moggs JG; Bateman DN; Goldring CE; Park BK
Hepatology; 2013 Aug; 58(2):777-87. PubMed ID: 23390034
[TBL] [Abstract][Full Text] [Related]
19. A Performance Evaluation of Liver and Skeletal Muscle-Specific miRNAs in Rat Plasma to Detect Drug-Induced Injury.
Bailey WJ; Barnum JE; Erdos Z; LaFranco-Scheuch L; Lane P; Vlasakova K; Sistare FD; Glaab WE
Toxicol Sci; 2019 Mar; 168(1):110-125. PubMed ID: 30496518
[TBL] [Abstract][Full Text] [Related]
20. The application of cytokeratin-18 as a biomarker for drug-induced liver injury.
Korver S; Bowen J; Pearson K; Gonzalez RJ; French N; Park K; Jenkins R; Goldring C
Arch Toxicol; 2021 Nov; 95(11):3435-3448. PubMed ID: 34322741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
